文献速递甲状腺核医学肿瘤 PET/CT

整合[18F]FDG数字PET/CT与颈部超声增强分化型甲状腺癌分期

Enhanced staging of differentiated thyroid carcinoma: integrating [18F]FDG digital PET/CT with neck ultrasound.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2025-02-25

本研究回顾性纳入82例高危甲状腺癌患者,术前均行颈部超声和数字[18F]FDG PET/CT并随访至少一年。基于患者分析,联合方案在中央区淋巴结的敏感度(44% vs 19%,p<0.05)和准确率(80% vs 72%,p<0.05)均优于单用超声。SUVratio是组织学侵袭性亚型、中央区转移和随访不完全反应的独立预测因子。

要点

  • 联合方案在中央区淋巴结的敏感度和准确率均优于单用超声(p<0.05)。
  • 病灶分析中联合方案整体优于单用PET/CT或超声(p<0.01)。
  • SUVratio是组织学侵袭性亚型、中央区转移和随访不完全反应的独立预测因子。

核心结论

  • 联合颈部[18F]FDG PET/CT与超声可改善分化型甲状腺癌患者的初始分期,并提供有价值的预后信息。

研究设计与样本

  • 回顾性评估在本中心连续治疗的高危甲状腺癌患者,术前均行颈部超声和颈部数字[18F]FDG PET/CT,并随访至少一年。
  • 共纳入82例患者(61例女性)。
  • 比较单用超声、单用[18F]FDG PET/CT和联合方案的诊断参数(敏感度和准确率),采用基于患者的分析,敏感度另采用基于病灶的分析。
  • 通过逻辑回归模型将临床和SUV参数与组织学及一年结局进行比较。

主要发现

  • 基于患者分析,联合方案在中央区淋巴结的敏感度为44% vs 单用超声19%(p<0.05),准确率为80% vs 单用超声72%(p<0.05)。
  • 基于病灶分析,联合方案整体优于单用[18F]FDG PET/CT和单用超声(敏感度分别为43%、37%和36%,p<0.01)。
  • 基于病灶分析,联合方案在中央区淋巴结的敏感度为25% vs 单用超声14%(p<0.01)。
  • SUVratio是组织学侵袭性分化型甲状腺癌亚型的独立预测因子(p=0.009)。
  • SUVratio是中央区转移的独立预测因子(p=0.04)。

临床怎么用

  • 原文结论认为联合颈部[18F]FDG PET/CT与超声可改善分化型甲状腺癌的初始分期并提供有价值的预后信息。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Accurate initial staging of differentiated thyroid carcinoma (DTC) is paramount to avoid disease persistence or relapses. Neck ultrasound (US) is the gold-standard examination for lymph node staging; however, it might miss the central compartment ones. [18F]FDG PET/CT has been used to characterise unclear or suspicious thyroid nodules and can also identify nodal disease. This study tested the diagnostic efficacy of a combined approach, including digital [18F]FDG PET/CT of the cervical region and neck US in DTC staging. METHODS: We retrospectively evaluated consecutive patients treated at our centre with high-risk thyroid who had had a neck US and a neck digital [18F]FDG PET/CT before surgery and at least one year of follow-up. Diagnostic parameters, including sensitivity (Se) and accuracy (Acc), were compared across US alone, [18F]FDG PET/CT alone, and the combined approach using a patient-based analysis (PBA); Se was also tested employing a lesion analysis (LBA). Clinical and SUV parameters were compared with the histology and the one-year outcome via a logistic regression model. RESULTS: Eighty-two patients (61 females) were included. At the PBA, the combined approach was superior to US alone regarding Se (44% vs 19%, p < 0.05) and Acc (80% vs 72%, p < 0.05) in the central compartment nodes. At the LBA, the combined approach was superior to either method overall (43%, 37%, and 36% for combined, [18F]FDG, and US, respectively, p < 0.01) and to US in the central nodes (25% vs 14%, p < 0.01). SUVratio was an independent predictor of histologically aggressive DTC variants (p = 0.009), central compartment metastases (p = 0.04), and incomplete response at follow-up (p = 0.004). CONCLUSIONS: The combined cervical [18F]FDG PET/CT / US approach improves the initial staging and harbours valuable prognostic information for DTC patients.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Piccardo A, Bottoni G, Treglia G, et al. Enhanced staging of differentiated thyroid carcinoma: integrating [18F]FDG digital PET/CT with neck ultrasound. Eur J Nucl Med Mol Imaging. 2025. PMID: 39998675. doi:10.1007/s00259-025-07169-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。